Intervention to support return to work in sick-listed employees with cancer: a randomized controlled trial.

• Conditions: Cancer; oncology; 10027656

• Registration Number: NL-OMON46377
• Lead Sponsor: TNO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 211

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- be of the working age (18-65 years).
- be diagnosed with a form of cancer matching the CAS codes described below.
- have a permanent contract with an employer, or a temporary contract with an employer which will end at least six months after start of the study.
- good command of the Dutch language, orally and in writing.;CAS codes
A209: Other Neoplasm (non-specified)
B200: Hodgkin lymphoma
B201: Leukemia
B209: Malignancies of the hematopoetic and lymphoid tissues
E209: Endocrine gland neoplasm
L200: Bone metastases
L209: Bone neoplasm
L219: Neoplasm in muscle- and connective tissues
N209: Meninges neoplasm (brain tissue)
N210: Central nervous system malignancies
N219: Central nervous system neoplasms (e.g. benign tumours)
N229: Neoplasms in the autonomous and peripheral nervous system
R200: Malignancies in the lungs or in bronchial tissue
R209: Other neoplasms in the respiratory tract (non-specified)
S200: Malignancies in the gasrto-intestinal tract
S201: Liver metastasis
S209: Other neoplasms in the gastro-intestinal tract (non-specified)
U200: Kidney, bladder and urinary malignancies
U219: Neoplasms in the male reproductive system
U229: Neoplasms in the mammae

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy.
- Severe comorbidities of physical or psychological nature that make participation from a medical perspective irresponsible (to judgement of the company doctor).
- matching one of the CAS codes described below.
- Already being signed up for a reintegration track at Re-turn or another intervention aimed at return to work at work (with an exception of recovery tracks being instated from the regular healthcare).
- Retirement within 24 months after reporting sick.
- The employee was already reported sick prior to an insurance agreement between the employer and the Amersfoorste Verzekeringen. ;CAS codes
A200: Kaposi sarcoma
C209: Non-specified neoplasms in the cardiovascular system
D200: Malignant melanoma
D201: Other malignancies in the skin and adnex (non-specified)
D209: Other neoplasms of the skin and adnex (non-specified)
H209: Ear and mastoïd neoplasms
U209: Other neoplasms in the kidney, bladder and urinary tract (non-specified)

Study & Design

• Study Type: Interventional
• Study Design: Not specified